CorMedix, Inc. (NYSE:CRMD)
Industry: Major Pharmaceuticals

OFF LIST - 711 consecutive market days: OFF LIST as of 08/07/2013 Through 11/14/2016

CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.

Current Quote*
Last: $1.155
Change: 0.135
Book: $Unk
Volume: 3,474,104

As Of: 11/19 16:05 ET
*Quotes delayed by 20min.

Graphs for CRMD


3 Month Graph


6 Month Graph


1 Year Graph